Salt / ingredient
Cilnidipine 10mg + Olmesartan Medoxomil 40mg
Lowers blood pressure
MRP data last verified: August 2026. Source: NPPA Pharma Sahi Daam, reproduced under the NPPA copyright policy.
Private-brand substitutes: kam se zyada
More about this medicine
Reference information
About Cilnidipine
This information is from US FDA labels, for reference only. Always follow your doctor's advice.
Common side effects
- nausea
- hyperuricemia
- dizziness
- upper respiratory infection ( 6
Safety advice
- Consult your doctor before use if pregnant or breastfeeding.
- May affect the kidneys. Tell your doctor if you have kidney problems.
- Stop use and seek emergency help if you have signs of a severe allergic reaction.
Uses
- lmesartan medoxomil and hydrochlorothiazide is indicated for the treatment of hypertension, to lower blood pressure.
- Olmesartan medoxomil and hydrochlorothiazide is not indicated for the initial therapy of hypertension .
- Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
- These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs.
- There are no controlled trials demonstrating risk reduction with olmesartan medoxomil and hydrochlorothiazide.
How to take
- he recommended starting dose of olmesartan medoxomil and hydrochlorothiazide is 40/12.5 mg once daily in patients whose blood pressure is not adequately controlled with olmesartan monotherapy.
- Dose can be titrated up to 40 /25 mg if necessary.
- The recommended starting dose of olmesartan medoxomil and hydrochlorothiazide is 20/12.5 mg once daily in patients whose blood pressure is not adequately controlled with monotherapy or who experience dose-limiting adverse reactions with hydrochlorothiazide.
- Patients titrated to the individual components (olmesartan and hydrochlorothiazide) may instead receive the corresponding dose of olmesartan medoxomil and hydrochlorothiazide.
- Recommended starting dose in patients not adequately controlled with olmesartan monotherapy, 40/12.5 mg ( 2 ) Recommended starting dose in patients not adequately controlled with hydrochlorothiazide monotherapy, 20/12.5 mg ( 2 ) Adjust dose after 2 to 4 weeks, as needed, to a maximum of 40 mg / 25 mg olmesartan / hydrochlorothiazide ( 2 )
Frequently Asked Questions about Cilnidipine 10mg + Olmesartan Medoxomil 40mg
What is the price of Cilnidipine 10mg + Olmesartan Medoxomil 40mg in India?
The price of Cilnidipine 10mg + Olmesartan Medoxomil 40mg in India depends on the manufacturer and channel. Official Government Jan Aushadhi generic rates start at ₹2.81 per unit.Private commercial brands vary from low-cost options to higher-priced branded formulations.
Is a Government Jan Aushadhi generic available for Cilnidipine 10mg + Olmesartan Medoxomil 40mg?
Cilnidipine 10mg + Olmesartan Medoxomil 40mg is listed under PMBI Jan Aushadhi (PMBI Code 2369) at ₹28.13 per pack.
How to find lower-cost substitutes for Cilnidipine 10mg + Olmesartan Medoxomil 40mg?
Search the active salt formulation (Cilnidipine 10mg + Olmesartan Medoxomil 40mg) on Sasta Parcha to view private-brand substitutes ranked strictly low-to-high by per-unit price. Always consult your prescribing doctor or pharmacist before changing medicine brands.